Validus Holdings, Ltd. (NYSE:VR) has earned a consensus rating of “Hold” from the eleven analysts that are currently covering the firm, Marketbeat Ratings reports. Two equities research analysts have rated the stock with a sell recommendation, five have issued a hold recommendation and three have assigned a buy recommendation to the company. The average 12-month price target among analysts that have covered the stock in the last year is $54.83.
VR has been the subject of several recent research reports. Keefe, Bruyette & Woods reissued a “hold” rating and issued a $51.00 price target on shares of Validus Holdings in a research note on Thursday, October 12th. BidaskClub raised Validus Holdings from a “strong sell” rating to a “sell” rating in a research note on Saturday, August 12th. UBS AG boosted their price target on Validus Holdings from $48.00 to $52.00 and gave the company a “neutral” rating in a research note on Monday. Bank of America Corporation raised Validus Holdings from a “neutral” rating to a “buy” rating in a research note on Monday. Finally, ValuEngine cut Validus Holdings from a “buy” rating to a “hold” rating in a research note on Wednesday, October 11th.
Shares of Validus Holdings (VR) traded up 2.50% on Wednesday, reaching $52.53. 1,167,005 shares of the company’s stock were exchanged. The company has a market capitalization of $4.17 billion, a P/E ratio of 14.49 and a beta of 0.65. Validus Holdings has a 12 month low of $41.15 and a 12 month high of $58.76. The firm’s 50 day moving average price is $49.01 and its 200-day moving average price is $51.88.
Validus Holdings (NYSE:VR) last announced its quarterly earnings results on Thursday, October 26th. The insurance provider reported ($3.22) EPS for the quarter, beating the Thomson Reuters’ consensus estimate of ($3.30) by $0.08. The business had revenue of $407.00 million during the quarter, compared to analysts’ expectations of $453.04 million. Validus Holdings had a negative return on equity of 0.47% and a negative net margin of 1.38%. The firm’s quarterly revenue was up 24.3% compared to the same quarter last year. During the same quarter in the previous year, the business posted $1.02 EPS. On average, equities analysts anticipate that Validus Holdings will post ($0.19) EPS for the current year.
Institutional investors have recently made changes to their positions in the business. UBS Asset Management Americas Inc. boosted its position in shares of Validus Holdings by 10.7% in the first quarter. UBS Asset Management Americas Inc. now owns 60,165 shares of the insurance provider’s stock valued at $3,393,000 after acquiring an additional 5,813 shares during the period. Legal & General Group Plc boosted its position in shares of Validus Holdings by 31.1% in the first quarter. Legal & General Group Plc now owns 65,459 shares of the insurance provider’s stock valued at $3,691,000 after acquiring an additional 15,528 shares during the period. Menta Capital LLC bought a new stake in shares of Validus Holdings in the first quarter valued at approximately $505,000. Vanguard Group Inc. boosted its position in shares of Validus Holdings by 1.8% in the first quarter. Vanguard Group Inc. now owns 6,193,054 shares of the insurance provider’s stock valued at $349,227,000 after acquiring an additional 112,237 shares during the period. Finally, Geode Capital Management LLC boosted its position in shares of Validus Holdings by 3.6% in the first quarter. Geode Capital Management LLC now owns 600,865 shares of the insurance provider’s stock valued at $33,882,000 after acquiring an additional 21,066 shares during the period. 94.64% of the stock is owned by hedge funds and other institutional investors.
Validus Holdings Company Profile
Validus Holdings, Ltd. is a holding company. The Company operates through four segments: Validus Re, Talbot, Western World and AlphaCat. Validus Re is a Bermuda-based reinsurance segment focused treaty reinsurance. Validus Re concentrates on first-party property and other reinsurance risks. Talbot is a specialty insurance segment operating within the Lloyd’s insurance market through Syndicate 1183.
Receive News & Ratings for Validus Holdings Ltd. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Validus Holdings Ltd. and related companies with MarketBeat.com's FREE daily email newsletter.